메뉴 건너뛰기




Volumn 1108, Issue , 2007, Pages 24-34

Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment

Author keywords

Arterial elasticity; Atherosclerosis; Hydroxychloroquine; SLE; Steroids

Indexed keywords

C REACTIVE PROTEIN; HYDROXYCHLOROQUINE; STEROID;

EID: 34948823831     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.003     Document Type: Conference Paper
Times cited : (47)

References (23)
  • 1
    • 0036181394 scopus 로고    scopus 로고
    • Inflammation in acute coronary syndromes
    • MULVIHILL, N.T., J.B. FOLEY. 2002. Inflammation in acute coronary syndromes. Heart 87: 201-204.
    • (2002) Heart , vol.87 , pp. 201-204
    • MULVIHILL, N.T.1    FOLEY, J.B.2
  • 2
    • 0033660004 scopus 로고    scopus 로고
    • FROHLICH, M., A. IMHOF, G. BERG, et al. 2000. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 1835-1839.
    • FROHLICH, M., A. IMHOF, G. BERG, et al. 2000. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 1835-1839.
  • 3
    • 0030956673 scopus 로고    scopus 로고
    • Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    • RIDKER, P.M., M. CUSHMAN, M.J. STAMPFER, et al. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 973-979.
    • (1997) N. Engl. J. Med , pp. 973-979
    • RIDKER, P.M.1    CUSHMAN, M.2    STAMPFER, M.J.3
  • 4
    • 0029810933 scopus 로고    scopus 로고
    • Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
    • KULLER, L.H., R.P. TRACY, J. SHATEN, et al. 1996. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 144: 537-547.
    • (1996) Am. J. Epidemiol , vol.144 , pp. 537-547
    • KULLER, L.H.1    TRACY, R.P.2    SHATEN, J.3
  • 5
    • 0028816015 scopus 로고
    • Is atherosclerosis an immunologically mediated disease?
    • WICK, G., G. SCHETT, A. AMBERGER, et al. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16: 27-33.
    • (1995) Immunol. Today , vol.16 , pp. 27-33
    • WICK, G.1    SCHETT, G.2    AMBERGER, A.3
  • 6
    • 0034090507 scopus 로고    scopus 로고
    • Autoimmunity in atherosclerosis: Lessons from experimental models
    • GEORGE, J., A. AFEK, B. GILBURD, et al. 2000. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9: 223-227.
    • (2000) Lupus , vol.9 , pp. 223-227
    • GEORGE, J.1    AFEK, A.2    GILBURD, B.3
  • 7
    • 0002528456 scopus 로고    scopus 로고
    • Vascularwall function as a risk marker for cardiovascular disease
    • COHN, J.N. 1999. Vascularwall function as a risk marker for cardiovascular disease. J. Hypertens. 17(Suppl 5): S41-S44.
    • (1999) J. Hypertens , vol.17 , Issue.SUPPL. 5
    • COHN, J.N.1
  • 8
    • 0032843358 scopus 로고    scopus 로고
    • Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease
    • COHN, J.N. 1999. Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease. Prog. Cardiovasc. Dis. 41: 441-450.
    • (1999) Prog. Cardiovasc. Dis , vol.41 , pp. 441-450
    • COHN, J.N.1
  • 9
    • 0031052874 scopus 로고    scopus 로고
    • Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosis: Comparison with the Framingham study
    • MANZI, S., E.N. MEILAHN, J.E. RAIRIE, et al. 1997. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosis: comparison with the Framingham study. Am. J. Epidemiol. 145: 408-415.
    • (1997) Am. J. Epidemiol , vol.145 , pp. 408-415
    • MANZI, S.1    MEILAHN, E.N.2    RAIRIE, J.E.3
  • 10
    • 0026459695 scopus 로고
    • Risk factors for coronary artery disease in patients with systemic lupus erythematosis
    • PETRI, M., S. PEREZ-GUTTHANN, D. SPENCE, et al. 1992. Risk factors for coronary artery disease in patients with systemic lupus erythematosis. Am. J. Med. 93: 513-519.
    • (1992) Am. J. Med , vol.93 , pp. 513-519
    • PETRI, M.1    PEREZ-GUTTHANN, S.2    SPENCE, D.3
  • 11
    • 0033004426 scopus 로고    scopus 로고
    • Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosis
    • WARD, M.M. 1999. Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosis. Arthritis Rheum. 42: 338-346.
    • (1999) Arthritis Rheum , vol.42 , pp. 338-346
    • WARD, M.M.1
  • 12
    • 0035050697 scopus 로고    scopus 로고
    • Vascular stiffness in women with systemic lupus erythematosis
    • SELZER, F., K. SUTTON-TYRRELL, S. FITZGERALD, et al. 2001. Vascular stiffness in women with systemic lupus erythematosis. Hypertension 37: 1075-1082.
    • (2001) Hypertension , vol.37 , pp. 1075-1082
    • SELZER, F.1    SUTTON-TYRRELL, K.2    FITZGERALD, S.3
  • 13
    • 0035673761 scopus 로고    scopus 로고
    • Atherosclerosis & connective tissue disease
    • MEYER O. 2001. Atherosclerosis & connective tissue disease. Joint Bone Spine 68: 564-575.
    • (2001) Joint Bone Spine , vol.68 , pp. 564-575
    • MEYER, O.1
  • 14
    • 0034761724 scopus 로고    scopus 로고
    • Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosis
    • ESDAILE, J.M., M. ABRAHAMOWICZ, T. GRODZICKY, et al. 2001. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosis. Arthritis Rheum. 44: 2331-2337.
    • (2001) Arthritis Rheum , vol.44 , pp. 2331-2337
    • ESDAILE, J.M.1    ABRAHAMOWICZ, M.2    GRODZICKY, T.3
  • 15
    • 0142156507 scopus 로고    scopus 로고
    • Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosis
    • DORIA, A., Y. SHOENFELD, R. WU, et al. 2003. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosis. Ann. Rheum. Dis. 62: 1071-1077.
    • (2003) Ann. Rheum. Dis , vol.62 , pp. 1071-1077
    • DORIA, A.1    SHOENFELD, Y.2    WU, R.3
  • 16
    • 0346030568 scopus 로고    scopus 로고
    • Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosis
    • ROMAN, M.J., B.A. SHANKER, D.A. LOCKSHIN, et al. 2003. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosis. N. Engl. J. Med. 349: 2399-2406.
    • (2003) N. Engl. J. Med , vol.349 , pp. 2399-2406
    • ROMAN, M.J.1    SHANKER, B.A.2    LOCKSHIN, D.A.3
  • 17
    • 13244268504 scopus 로고    scopus 로고
    • Determination of arterial compliance using blood pressure waveform analysis, with the CR-2000 system - reliability, repeatability and establishment of normal values for healthy European population. The Seven European Sites Study (SESS)
    • ZIMLICHMAN, R., M. BOAZ, M. SHARGORODSKY, et al. 2005. Determination of arterial compliance using blood pressure waveform analysis, with the CR-2000 system - reliability, repeatability and establishment of normal values for healthy European population. The Seven European Sites Study (SESS). Am. J. Hypertension. 1:8 65-71.
    • (2005) Am. J. Hypertension , vol.1 , Issue.8 , pp. 65-71
    • ZIMLICHMAN, R.1    BOAZ, M.2    SHARGORODSKY, M.3
  • 18
    • 0029764927 scopus 로고    scopus 로고
    • Thrombosis and systemic lupus erythematosis: The Hopkins Lupus Cohort perspective
    • PETRI, M. 1996. Thrombosis and systemic lupus erythematosis: the Hopkins Lupus Cohort perspective. Scand. J. Rheumatol. 25: 191-193.
    • (1996) Scand. J. Rheumatol , vol.25 , pp. 191-193
    • PETRI, M.1
  • 19
    • 0016644434 scopus 로고
    • Inhibitors of platelet function in the prevention of arterial thrombosis
    • HARKER, L.A. 1975. Inhibitors of platelet function in the prevention of arterial thrombosis. Ser. Haematol. 8: 105-124.
    • (1975) Ser. Haematol , vol.8 , pp. 105-124
    • HARKER, L.A.1
  • 20
    • 0029990745 scopus 로고    scopus 로고
    • Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
    • PETRI, M. 1996. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5(Suppl 1): S16-S22.
    • (1996) Lupus , vol.5 , Issue.SUPPL. 1
    • PETRI, M.1
  • 21
    • 0032900519 scopus 로고    scopus 로고
    • The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs
    • RAHMAN, P., D.D. GLADMAN, M.B. UROWITZ, et al. 1999. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J. Rheumatol. 26: 325-330
    • (1999) J. Rheumatol , vol.26 , pp. 325-330
    • RAHMAN, P.1    GLADMAN, D.D.2    UROWITZ, M.B.3
  • 22
    • 0033601472 scopus 로고    scopus 로고
    • Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats
    • EMAMI, J., F.M. PASUTTO, J.R. MERCER, et al. 1999. Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. Life Sci. 64: 325-335.
    • (1999) Life Sci , vol.64 , pp. 325-335
    • EMAMI, J.1    PASUTTO, F.M.2    MERCER, J.R.3
  • 23
    • 0036175209 scopus 로고    scopus 로고
    • The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial
    • GERSTEIN, H.C., K.E. THORPE, D.W. TAYLOR, et al. 2002. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial. Diabetes Res. Clin. Pract. 55: 209-219.
    • (2002) Diabetes Res. Clin. Pract , vol.55 , pp. 209-219
    • GERSTEIN, H.C.1    THORPE, K.E.2    TAYLOR, D.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.